Severe prognosis in a large family with hypokalemic periodic paralysis

Muscle and Nerve

Volumn 27, Issue 2, 2003, Pages 165-169

  Caciotti, Anna ^a   Morrone, Amelia ^a   Domenici, Raffaele ^b   Donati, Maria Alice ^a   Zammarchi, Enrico ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Azienda Sanitaria Locale n2 ^*  (Italy)

Author keywords

Channel disorders; Genotype phenotype correlation; Hypokalemic periodic paralysis; Malignant hyperthermia; R528H

Indexed keywords

CALCIUM CHANNEL; DIHYDROPYRIDINE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANESTHESIA COMPLICATION; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; FAMILY; FEMALE; GENETIC TRAIT; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; ITALY; LIFESPAN; MALE; MALIGNANT HYPERTHERMIA; MOLECULAR BIOLOGY; MORTALITY; PENETRANCE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; ELECTROCARDIOGRAPHY; FAMILY HEALTH; FEMALE; HUMANS; HYPOKALEMIA; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MUSCLE WEAKNESS; PEDIGREE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 0037309797     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10298     Document Type: Article

References (29)

1. Barone V, Massa O, Intravaia E, Bracco A, Di Martino A, Tegazzin V, Cozzolino S, Sorrentino V. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families. J Med Genet 1999; 36:115-118.
2. Bulman DE, Scoggan KA, van Oene M D, Nicolle MW, Hahn AF, Tollar LL, Ebers GC. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 1999;53:1932-1936.
3. Catterall WA. Structure and function of the voltage-sensitive ion channels. Science 1988;242:50-61.
4. Dubovitz V. Muscle disorder in childhood. London: WB Saunders; 1995. p 266-269.
5. Elbaz A, Vale-Santos J, Jurkat-Rott K, Lapie P, Ophoff RA, Bady B, Links TP, Piussan C, Vila A, Monnier N, Padberg GW, Abe K, Feingold N, Guimaraes J, Wintzen AR, van der Hoeven JH, Saudubray, JM, Grunfeld JP, Lenoir G, Nivet H, Echenne B, Frants RR, Fardeau M, Lehmann-Horn F, Fontaine B. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1995;56:374-380.
6. Fontaine B, Vale-Santos J, Jurkat-Rott K, Reboul J, Plassart E, Rime CS, Elbaz A, Heine R, Guimaraes J, Weissenbach J, Baumann N, Fardeau M, Lehmann-Horn F. Mapping of the hypokalemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet 1994;6:267-272.
7. Fouad G, Dalakas M, Servisei S, Mendell JR, Van den Bergh P, Angelini, C, Alderson K, Griggs RC, Tawil R, Gregg R, Hogan K, Powers PA, Weinberg N, Malonee W, Ptacek LJ. Genotype-phenotype correlations of DHP-receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord 1997;7:33-38.
8. Hogan K, Gregg R G, Powers PA. The structure of the gene encoding the human skeletal muscle alpha-1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics 1996;31:392-394.
9. Horton B. Anesthetic experiences in a family with hypokalemic familial periodic paralysis. Anesthesiology 1977;47:308-310.
10. Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg RG, Hogan K, Powers P A, Lapie, P, Vale-Santos JE, Weissenbach J, Fontaine B. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Molec Genet 1994;3:1415-1419.
11. Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, Lerc H, Nicole S, Vale-Santos J, Chauveau D, Fontaine B, Lehmann-Horne F. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 2000;97:9549-9554.
12. Kramer LD, Cole JP, Messenger JC, Ellestad MH. Cardiac dysfunction in a patient with familial hypokalemic periodic paralysis. Chest 1979;75:189-192.
13. Lambert C, Blanloeil Y, Krisovic Horber R, Berard L, Reyford H, Pinaud M. Malignant hyperthermia in a patient with hypokalemic periodic paralysis. Anesth Analg 1994;79:1012-1014.
14. Lema G, Urzua J, Moran S, Canessa R. Successful anesthetic management of a patient with hypokalemic familial periodic paralysis undergoing cardiac surgery. Anesthesiology 1991;74:373-375.
15. Manning BM, Quane KA, Ording H, Urwyler A, Tegazzin V, Lehane M, O'Halloran J, Hartung E, Giblin LM, Lynch PJ, Vaughan P, Censier K, Bendixen D, Comi G, Heytens L, Monsieurs K, Fagerlund T, Wolz W, Heffron JJ, Muller CR, McCarthy TV. Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation. Am J Hum Genet 1998;62: 599-609.
16. McCarthy TV, Quane KA, Lynch PJ. Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 2000;15:410-417.
17. Melnick B, Chang J, Larson C, Bedger R. Hypokalemic familial periodic paralysis. Anesthesiology 1983;58:263-265.
18. Monnier N, Procaccio V, Stieglitz P, Lunardi J. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha-1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997;60:1316-1325.
19. Perez-Reyes E, Kim HS, Lacerda AE, Horne W, Wei X, Rampe D, Campbell K, Brown AM, Birnbaumer L. Induction of calcium currents by the expression of the α1 subunit from the dihydropyridine receptor of skeletal muscle. Nature 1989; 340:233-236.
20. Rajabally YA, El Lahawi M. Hypokalemic periodic paralysis associated with malignant hyperthermia. Muscle Nerve 2002; 25:453-455.
21. Riggs JE. Periodic paralysis. Clin Neuropharmacol 1989;12: 249-257.
22. Rollman JE, Dickson CM. Anesthetic management of a patient with hypokalemic familial periodic paralysis for coronary artery bypass surgery. Anesthesiology 1985;63:526-527.
23. Rueffert H, Olthoff D, Deutrich C, Froster UG. Determination of a positive malignant hyperthermia (MH) disposition without the in vitro contracture test in families carrying the RYR1 Arg614Cys mutation. Clin Genet 2001;60:117-124.
24. Sambuughin N, McWilliams S, de Bantel A, Sivakumar K, Nelson TE. Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype. Am J Hum Genet 2001;69:204-208.
25. Sambuughin N, Nelson TE, Jankovic J, Xin C, Meissner G, Mullakandov M, Ji J, Rosenberg H, Sivakumar K, Goldfarb LG. Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families. Neuromuscul Disord 2001;11:530-537.
26. Sambuughin N, Sei Y, Gallagher KL, Wyre HW, Madsen D, Nelson TE, Fletcher JE, Rosenberg H, Muldoon SM. North American malignant hyperthermia population: screening of tile ryanodine receptor gene and identification of novel mutations. Anesthesiology 2001;95:594-549.
27. Siler JN, Discavage WJ. Anesthetic management of hypokalemic periodic paralysis. Anaesthesiology 1975;43:489-490.
28. Sipos I, Jurkat-Rott K, Harasztosi CS, Fontaine B, Kovacs L, Melzer W, Lehmann-Horn F. Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes. J Physiol 1995;483:299-306.
29. Viscomi CM, Ptacek LJ, Dudley D. Anesthetic management of familial hypokalemic periodic paralysis during parturition. Anesth Analg 1999;88:1081-1082. 170-173; 176-179